Medical News

RSS

Biomatrica launches DNAgard Blood and DNAstable Blood sample stabilization products

Biomatrica Inc., the leader in room temperature biological sample stabilization, today announced the release of DNAgard® Blood and DNAstable® Blood.

22 Sep 2010

Seredor acquires United Sleep Diagnostics to expand sleep diagnostic activities

Continucare Corporation announced today that its wholly owned subsidiary Seredor Corporation has further expanded its sleep diagnostic activities through the acquisition of United Sleep Diagnostics, Inc., an operator of sleep diagnostic centers. The acquired business currently operates three independent testing facilities and manages sleep centers at six hospitals located in Miami-Dade, Broward and Palm Beach Counties, Florida.

22 Sep 2010

GATC Biotech to purchase PacBio real-time sequencing technology

GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT™) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.

22 Sep 2010

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.

22 Sep 2010

Nationwide Health Information Network tool to convey public health information

One hundred and sixty-six years after Samuel Morse used dots and dashes to telegraph "What hath God wrought?" opening up a whole new world of communication, Indiana has become the first state in the nation to use a potentially equally revolutionary tool, the Nationwide Health Information Network, to convey public health information to the U.S. Centers for Disease Control and Prevention.

22 Sep 2010

Scientists develop new therapy for treatment of skin, lung cancer

Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) that can induce death to cells transfected with it.. Their studies have demostrated that this technique is not only effective in vitro (using tumour cell cultures), but also in vivo through the use of experimental animals in which tumours were induced.

22 Sep 2010

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant from the National Institute on Drug Abuse to develop an integrated systems biology platform for research into the causes and treatment of tobacco dependence, nicotine addiction, smoking cessation and tobacco/nicotine withdrawal.

22 Sep 2010

G-CSF compound may activate virus, increases risk of infection: Research

Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute may spur debate about the risks associated with administering a specific compound in some forms of bone-marrow transplantation. The research is published in the current edition of Cell Host and Microbe.

22 Sep 2010

Valeant prices offering of senior unsecured notes

Valeant Pharmaceuticals International announced today that it has priced its previously announced offering of senior unsecured notes, which consists of $500 million of 6.75% Senior Notes due 2017 and $700 million of 7.00% Senior Notes due 2020 (collectively, the "Notes"). The $1.2 billion combined aggregate principal amount of the Notes was increased from the previously announced offering size of $1.0 billion. The offering is expected to close on or about September 28, 2010.

22 Sep 2010

CPPR expresses concern over recently passed health care bill's flaws

Coalition to Protect Patients Rights spokesman Donald J. Palmisano, MD, expressed concern this week over the recently passed health care bill's flaws after new survey results indicated that overall health care costs actually will increase following the bill's passage.

22 Sep 2010

Titan completes enrollment in Probuphine Phase 3 study for opioid addiction

Titan Pharmaceuticals, Inc. today announced that patient enrollment is now complete in the confirmatory, Phase 3 clinical study of Probuphine for the treatment of opioid addiction. This placebo and active controlled Phase 3 study is being conducted at 20 sites in the United States and the results are expected in the second quarter of 2011, about three months ahead of the original schedule.

22 Sep 2010

Santaris Pharma paves way to conduct clinical trial of miravirsen in patients with HVC

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.

22 Sep 2010

The AFA to acknowledge use of media in family building, infertility

The American Fertility Association, a 501 (c)(3) national non-profit organization, will recognize the media's role in family building and infertility. Illuminations - an event celebrating the accomplishments of individuals and organizations who have made a positive impact in the fields of reproductive health, family building and fertility - is coming to New York City.

22 Sep 2010

First Edition: September 22, 2010

Today's headlines focus on news surrounding tomorrow's six-month anniversary of the new health law and some of the specific provisions that will kick in on that day.

22 Sep 2010

AMS reports 12-month study results of Elevate Apical and Posterior Prolapse Repair System

American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of a 12-month single-arm, prospective multi-center study of the Elevate® Apical and Posterior Prolapse Repair System. The pelvic organ prolapse quantification exam (POP-Q), used to quantify, describe, and stage pelvic support, was implemented in the study and concluded efficacy rates of Stage 1 or less to be 89.2% for Apical and 91.7% for Posterior.

22 Sep 2010

Viking Systems to demonstrate 3DHD Visualization System at Sony's media event

Viking Systems, Inc. announced today its Next Generation 3DHD Visualization System for use in minimally invasive surgery will be prominently featured at Sony's media event to be held September 23, 2010 at Sony's offices in New York, NY. Jed Kennedy, Viking Systems President and CEO and Gerald Andriole, M.D., Medical Advisor to Viking Systems will address the media and explain the features and benefits of the system.

22 Sep 2010

Vascular Disease Foundation honors UCSD professor with President's Award for Vision

The Vascular Disease Foundation has awarded Michael Criqui, MD, MPH, professor and chief of the Division of Preventive Medicine in the Department of Family and Preventive Medicine at the University of California, San Diego, one of its highest honors, the President's Award for Vision. The award was presented at the VDF's annual meeting in Alexandria, Virginia on September 20.

22 Sep 2010

Study finds certain MRI sequences as accurate methods of assessing stent stenosis

Researchers have found that magnetic resonance imaging (MRI) may be sufficient for the routine surveillance of some great vessel (primary blood vessels [e.g., aorta and vena cavae]) stents that are commonly used to treat congenital heart defects (a defect in the structure of the heart and great vessels that is present at birth) in children and young adults, according to a study in the October issue of the American Journal of Roentgenology (www.ajronline.org). MRI is a noninvasive medical test that helps physicians diagnose and treat medical conditions.

22 Sep 2010

Researchers investigate performance levels of resident and staff physicians

Research on the quality of US resident physician performance levels has often been limited by lack of a comparison group or strict focus on specific diseases and geographical areas. In order to gain insight on differences in quality of care provided by resident physicians versus staff physicians, Boston Medical Center and Palo Alto Medical Foundation researchers investigated performance of physicians in 33,900 hospital-based outpatient visits throughout the US.

22 Sep 2010

Study: Stricture recurrence rate is low, recurrence can be retreated endoscopically

Researchers from Italy have reported results from more than 10 years of follow-up showing that the placement of multiple endoscopic stents for the treatment of postoperative biliary strictures remains excellent with a low rate of stricture recurrence after this lengthy period of time. When strictures do recur, they can be safely and successfully retreated endoscopically. The study appears in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).

22 Sep 2010

Medical News

Biomatrica launches DNAgard Blood and DNAstable Blood sample stabilization products

Seredor acquires United Sleep Diagnostics to expand sleep diagnostic activities

GATC Biotech to purchase PacBio real-time sequencing technology

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Nationwide Health Information Network tool to convey public health information

Scientists develop new therapy for treatment of skin, lung cancer

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

G-CSF compound may activate virus, increases risk of infection: Research

Valeant prices offering of senior unsecured notes

CPPR expresses concern over recently passed health care bill's flaws

Titan completes enrollment in Probuphine Phase 3 study for opioid addiction

Santaris Pharma paves way to conduct clinical trial of miravirsen in patients with HVC

The AFA to acknowledge use of media in family building, infertility

First Edition: September 22, 2010

AMS reports 12-month study results of Elevate Apical and Posterior Prolapse Repair System

Viking Systems to demonstrate 3DHD Visualization System at Sony's media event

Vascular Disease Foundation honors UCSD professor with President's Award for Vision

Study finds certain MRI sequences as accurate methods of assessing stent stenosis

Researchers investigate performance levels of resident and staff physicians

Study: Stricture recurrence rate is low, recurrence can be retreated endoscopically

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News